Table 2.
Antimicrobial consumption in pigs in the Netherlands in 2012 expressed in numbers of DDDANL/Y, ADDDK/Y and DADDDK/Y per therapeutic group and per farm type and the proportion of DADDDK/Y to DDDANL/Y
| DDDANL/Y | ADDDK/Y | DADDDK/Y | Proportion DADDDK/Y to DDDANL/Yb (%) | |
|---|---|---|---|---|
| Sows/piglets farms | ||||
| Amphenicols | 0.060 | 0.030 | 0.060 | 100.0 |
| Aminoglycosides | 0.004 | 0.003 | 0.003 | 76.7 |
| Cephalosporins 3rd/4th gen. | 0.001 | 0.001 | 0.001 | 100.0 |
| Combinations | 0.290 | 0.236 | 0.185 | 63.6 |
| Fluoroquinolones | 0.001 | 0.001 | 0.001 | 87.7 |
| Macrolides/lincosamides | 1.776 | 1.798 | 1.610 | 90.7a |
| Penicillins | 5.685 | 3.882 | 3.580 | 63.0 |
| Pleuromutilines | 0.736 | 0.513 | 0.629 | 85.4 |
| Polymyxines | 1.207 | 1.199 | 1.815 | 150.4 |
| Tetracyclines | 6.931 | 6.640 | 5.778 | 83.3 |
| Trimethoprim/sulfonamidesc | 2.513 | 1.710 | 1.659 | 66.0 |
| Total | 19.20 | 16.01 | 15.32 | |
| Finisher pigs farms | ||||
| Amphenicols | 0.069 | 0.035 | 0.069 | 100.0 |
| Aminoglycosides | - | - | - | - |
| Cephalosporins 3rd/4th gen. | 0.000 | 0.000 | 0.000 | 100.0 |
| Combinations | 0.081 | 0.062 | 0.051 | 62.2 |
| Fluoroquinolones | 0.000 | 0.000 | 0.000 | 85.6 |
| Macrolides/lincosamides | 1.254 | 2.216 | 2.144 | 171.0a |
| Penicillins | 1.003 | 0.736 | 0.619 | 61.7 |
| Pleuromutilines | 0.099 | 0.073 | 0.077 | 78.0 |
| Polymyxines | 0.169 | 0.167 | 0.253 | 149.9 |
| Tetracyclines | 7.454 | 7.320 | 6.297 | 84.5 |
| Trimethoprim/sulfonamidesc | 1.651 | 0.958 | 0.918 | 55.6 |
| Total | 11.78 | 11.57 | 10.43 |
aA detailed analysis of this group of antimicrobials is performed on product level. See text for details
bThis calculation is based on the unrounded numbers of DADDDK/Y and DDDANL/Y
cTrimethoprim/sulphonamides by oral use, applied in combination